1. Home
  2. NVX vs GNLX Comparison

NVX vs GNLX Comparison

Compare NVX & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

SELL

Current Price

$2.57

Market Cap

95.9M

Sector

Miscellaneous

ML Signal

SELL

Logo Genelux Corporation

GNLX

Genelux Corporation

BUY

Current Price

$2.59

Market Cap

110.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NVX
GNLX
Founded
2012
2001
Country
Australia
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.9M
110.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
NVX
GNLX
Price
$2.57
$2.59
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $18.83
AVG Volume (30 Days)
26.7K
★ 210.7K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.47
EPS
★ N/A
N/A
Revenue
N/A
★ $8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8,993.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$2.29
52 Week High
$4.60
$8.54

Technical Indicators

Market Signals
Indicator
NVX
GNLX
Relative Strength Index (RSI) 53.27 49.74
Support Level $0.92 $2.51
Resistance Level $3.36 $2.93
Average True Range (ATR) 0.17 0.12
MACD -0.12 0.02
Stochastic Oscillator 23.70 68.57

Price Performance

Historical Comparison
NVX
GNLX

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: